The race for dominance in the artificial intelligence memory market is entering a new phase. Samsung Electronics has announced that it is nearing Nvidia’s certification for its latest HBM4 memory chips, a move that could enable mass deliveries as early as February 2026 and potentially reshape the balance of power in the premium memory segment.
HBM4 is a critical component of modern AI accelerators. The new generation of high-bandwidth memory delivers higher throughput and improved energy efficiency, enabling faster processing of massive data sets while reducing operating costs in data centers. Large-scale availability of HBM remains one of the key bottlenecks in the expansion of AI infrastructure.
Samsung and SK Hynix plan to begin parallel HBM4 production in February, although full-scale output may be pushed into the second quarter due to Nvidia’s stringent quality requirements. For the GPU maker, this represents further diversification of its supply chain at a time of rapidly growing demand for AI accelerators.
News of Samsung’s progress has also impacted competitors. Shares of Micron Technology are down by around 2% in today’s session, a move the market interprets as a sign of intensifying competitive pressure in the HBM memory segment. At the same time, demand for HBM4 continues to outstrip supply, with all major manufacturers still in the qualification process and expanding production capacity.
Samsung’s advances in securing HBM4 certification underscore that the battle in the memory market is entering a decisive stage. Competitive advantage is increasingly determined not only by technological performance, but also by the ability to rapidly scale production and meet the strict requirements of the largest AI chip customers.
Source: xStation5
Source: xStation5
Daily summary: Silver plunges 9% 🚨Indices, crypto and precious metals under pressure
Does the current sell-off signal the end of quantum companies?
Howmet Aerospace surges 10% after earnings reaching $100 bilion market cap 📈
US Open: Cisco Systems slides 10% after earnings 📉 Mixed sentiments on Wall Street
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
